Eosinophilic fasciitis associated with L-tryptophan ingestion.
AUTOR(ES)
Hamilton, M E
RESUMO
A 62 year old woman taking L-tryptophan developed eosinophilic fasciitis shortly after starting an exercise class. She received prednisone without benefit but improved after azathioprine treatment was started and L-tryptophan was discontinued. As products containing L-tryptophan have recently been implicated in development of the eosinophilia-myalgia syndrome it is suggested that the use of L-tryptophan might have contributed to the development of eosinophilic fasciitis in this patient. Similarities with toxic oil syndrome are noted. Additional studies are warranted to determine the prevalence of L-tryptophan ingestion among patients diagnosed as having eosinophilic fasciitis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1004327Documentos Relacionados
- Induction by l-Tryptophan and an Analogue, α-Methyl-dl-Tryptophan, of the Enzymes Catabolizing l-Tryptophan in Pseudomonas
- l-Tryptophan Production by Achromobacter liquidum
- L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.
- Microbiological Method for the Determination of l-Tryptophan
- Pathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis rats.
